A detailed history of Dimensional Fund Advisors LP transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 11,669,375 shares of GILD stock, worth $1.09 Billion. This represents 0.24% of its overall portfolio holdings.

Number of Shares
11,669,375
Previous 10,412,413 12.07%
Holding current value
$1.09 Billion
Previous $714 Million 36.92%
% of portfolio
0.24%
Previous 0.19%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$66.59 - $83.99 $83.7 Million - $106 Million
1,256,962 Added 12.07%
11,669,375 $978 Million
Q2 2024

Aug 09, 2024

BUY
$63.15 - $72.88 $16.9 Million - $19.5 Million
268,208 Added 2.64%
10,412,413 $714 Million
Q1 2024

May 10, 2024

BUY
$71.58 - $87.29 $25.8 Million - $31.5 Million
361,010 Added 3.69%
10,144,205 $743 Million
Q4 2023

Feb 07, 2024

BUY
$73.27 - $83.09 $21 Million - $23.9 Million
287,080 Added 3.02%
9,783,195 $793 Million
Q3 2023

Nov 09, 2023

BUY
$73.94 - $80.67 $30.6 Million - $33.4 Million
414,378 Added 4.56%
9,496,115 $712 Million
Q2 2023

Aug 09, 2023

BUY
$76.01 - $86.7 $4.75 Million - $5.41 Million
62,444 Added 0.69%
9,081,737 $700 Million
Q1 2023

May 12, 2023

BUY
$77.31 - $88.08 $3.6 Million - $4.1 Million
46,564 Added 0.52%
9,019,293 $748 Million
Q4 2022

Feb 09, 2023

SELL
$62.32 - $89.47 $7.24 Million - $10.4 Million
-116,113 Reduced 1.28%
8,972,729 $770 Million
Q3 2022

Nov 10, 2022

BUY
$59.54 - $68.01 $16.7 Million - $19.1 Million
280,256 Added 3.18%
9,088,842 $561 Million
Q2 2022

Aug 12, 2022

BUY
$57.72 - $65.01 $16.6 Million - $18.7 Million
286,885 Added 3.37%
8,808,586 $544 Million
Q1 2022

May 13, 2022

BUY
$57.92 - $72.58 $71.3 Million - $89.4 Million
1,231,734 Added 16.9%
8,521,701 $507 Million
Q4 2021

Feb 09, 2022

BUY
$64.88 - $73.64 $35.1 Million - $39.9 Million
541,329 Added 8.02%
7,289,967 $529 Million
Q3 2021

Nov 12, 2021

BUY
$67.69 - $73.03 $60.5 Million - $65.3 Million
894,368 Added 15.28%
6,748,638 $471 Million
Q2 2021

Aug 12, 2021

BUY
$63.47 - $69.35 $91.1 Million - $99.6 Million
1,435,775 Added 32.49%
5,854,270 $403 Million
Q1 2021

May 14, 2021

SELL
$60.0 - $68.46 $40.3 Million - $45.9 Million
-671,039 Reduced 13.18%
4,418,495 $286 Million
Q4 2020

Feb 25, 2021

BUY
$56.65 - $64.55 $288 Million - $329 Million
5,089,534 New
5,089,534 $296 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $117B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.